A detailed history of Alphabet Inc. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 4,256,175 shares of RVMD stock, worth $235 Million. This represents 13.2% of its overall portfolio holdings.

Number of Shares
4,256,175
Previous 5,307,075 19.8%
Holding current value
$235 Million
Previous $206 Million 6.37%
% of portfolio
13.2%
Previous 12.96%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$36.92 - $47.94 $38.8 Million - $50.4 Million
-1,050,900 Reduced 19.8%
4,256,175 $193 Million
Q2 2024

Aug 01, 2024

BUY
$30.14 - $40.68 $167,668 - $226,302
5,563 Added 0.1%
5,307,075 $206 Million
Q4 2023

Feb 08, 2024

BUY
$18.35 - $34.12 $97.3 Million - $181 Million
5,301,512 New
5,301,512 $152 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.83B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Alphabet Inc. Portfolio

Follow Alphabet Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphabet Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alphabet Inc. with notifications on news.